Two hundred seventy patients undergoing PDG for gastric cancer were randomly assigned NG/NJT placement ( NG/NJT group ) or not ( no-NG/NJT group ) with either Billroth II gastrojejunostomy or Roux-en-Y gastrojejunostomy .